In genomics, beyond FGFR3 mutations as important predictive and prognostic markers, other genetic alterations such as TP53, RB1, and PIK3CA also play key roles in the development and progression of bladder cancer (9, 10). The gene discussed is FGFR3; the disease is urinary bladder cancer.